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Wing developmentGeminin was identiﬁed in Xenopus as a dual function protein involved in the regulation of DNA replication
and neural differentiation. In Xenopus, Geminin acts to antagonize the Brahma (Brm) chromatin-remodeling
protein, Brg1, during neural differentiation. Here, we investigate the interaction of Geminin with the Brm
complex during Drosophila development. We demonstrate that Drosophila Geminin (Gem) interacts
antagonistically with the Brm–BAP complex during wing development. Moreover, we show in vivo during
wing development and biochemically that Brm acts to promote EGFR–Ras–MAPK signaling, as indicated by
its effects on pERK levels, while Gem opposes this. Furthermore, gem and brm alleles modulate the wing
phenotype of a Raf gain-of-function mutant and the eye phenotype of a EGFR gain-of-function mutant.
Western analysis revealed that Gem over-expression in a background compromised for Brm function
reduces Mek (MAPKK/Sor) protein levels, consistent with the decrease in ERK activation observed. Taken
together, our results show that Gem and Brm act antagonistically to modulate the EGFR–Ras–MAPK signaling
pathway, by affecting Mek levels during Drosophila development.
Crown Copyright © 2010 Published by Elsevier Inc. All rights reserved.Introduction
During development coordination between cell proliferation and
terminal differentiation is critical to enable cells to cease division and
differentiate appropriately. In order to achieve this, tight regulation of
the cell cycle occurs, predominantly at the G1 to S-phase transition, to
allow the appropriate response to external signals (Hunter and Pines,
1994). The G1- to S-phase transition is driven by the regulated activity
of G1 Cyclin/Cyclin-dependent kinase (Cdk) complexes, Cyclin D/
Cdk4(6) and Cyclin E/Cdk2 (Reed, 1997). These kinases drive the G1
to S-phase progression by phosphorylating key substrates that are
required for S-phase gene transcription and for the initiation of DNA
replication. To ensure that DNA is replicated only once per cell cycle
the initiation of DNA replication requires periodic activation and
inactivation of G1 Cyclin/CDKs, as assembly of the pre-replication
complex (pre-RC) at replication origins can only occur during low Cdk
activity period (late mitosis to G1) (Bell and Dutta, 2002; Difﬂey,
2004; Fujita, 1999). Assembly of the pre-RC or “licensing reaction”enter, St Andrews Place, East
.E. Richardson).
t.
10 Published by Elsevier Inc. All riginvolves loading the Mini-Chromosome-Maintenance (MCM) protein
complex onto chromatin by the origin recognition complex (ORC) and
two essential factors, CDC6 and Cdt1 (Maiorano et al., 2000; Nishitani
et al., 2000). In yeast, the periodic activation and inactivation of Cdk
activity is sufﬁcient to enable licensing, however in more complex
eukaryotes, an additional control mechanism has been discovered. In
Drosophila, Xenopus and mammals, Geminin binds Cdt1, preventing
the loading of the MCMs onto the chromatin and thereby suppressing
inappropriate re-assembly of the pre-RC during S-, G2- and M-phase
(Lygerou and Nurse, 2000; McGarry and Kirschner, 1998; Wohls-
chlegel et al., 2000).
Geminin is a bi-functional protein in Xenopus, whose C-terminal
cell cycle domain can inhibit DNA replication and whose N-terminal
neuralization domain has an essential role in specifying neural cell
fate (Kroll et al., 1998; McGarry and Kirschner, 1998). In Drosophila,
Geminin (Gem) is expressed in dividing cells, including the
neuroblasts of the peripheral (PNS) and central nervous systems
(CNS), and is down-regulatedwhen cells stop dividing and commence
differentiation (Quinn et al., 2001). Our previous studies showed that
gemmutant embryos over-replicate DNA exhibiting anaphase defects,
as well as a loss of the dorsal-most peripheral neurons in late stage
embryos (Quinn et al., 2001). Conversely, ectopic expression of
Drosophila Gem inhibits DNA replication and cells enter mitosis withhts reserved.
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over-expression of Gem leads to ectopic neural cells in the embryonic
epidermis. However, from these studies it was unclear whether these
ectopic neural cells are a result of cell cycle defects or reﬂect a more
speciﬁc role for Gem in neural differentiation.
Xenopus Geminin was shown to functionally interact with the
catalytic subunit of the SWI/SNF chromatin-remodeling complex,
resulting in changes in transcription (Seo et al., 2005). This study also
showed that Geminin controls the transition from proliferating
precursors to differentiated post-mitotic neurons by modulating
interactions between SWI/SNF and bHLH transcription factors that
are critical for neurogenesis (Seo et al., 2005). In other developmental
contexts, for example during eye development in the ﬁsh, Medaka, and
during neural tube development in the chicken, Geminin mediates
proliferative-differentiation transitions through interactions with the
transcription factors Six3 and Hox, as well as Polycomb Group proteins
(Del Bene et al., 2004; Luo et al., 2004). Interactions between Geminin
and transcription factors, or the Polycomb or SWI/SNF chromatin-
remodeling complex proteins reveal a novel role for Geminin in
transcriptional control. In the yeast, Saccharomyces cerevisiae, the SWI/
SNF protein complex functions through ATP-dependent chromatin
remodeling to control gene expression at speciﬁc promoters (Kingston
et al., 1996). Mammalian homologs of the Swi2 ATPase subunit, Brahma
(Brm) and Brg1, induce cell cycle arrest when ectopically expressed
(Bultman et al., 2000; Muchardt and Yaniv, 2001). Furthermore, Brm
knockout mice show hyperplasia of organs (Reyes et al., 1998), while
Brg1 knockouts are early embryonic lethal, but heterozygous mice are
predisposed to tumor formation (Bultman et al., 2000). Taken together
these studies demonstrate interactions between Geminin and tran-
scription factors, the Polycomb complex or the SWI/SNF (Brm or Brg1)
chromatin-remodeling complex, and reveal roles for Geminin in the
transcriptional control of cell cycle exit and differentiation.
In Drosophila the SWI/SNF homologue brahma (brm) is an
essential gene (Elfring et al., 1998). brm mutants show a decrease in
viability and defects in the peripheral nervous system (PNS) of adults.
Furthermore, a dominant-negative form of brahma, brmK0804R,
(brmDN) which is defective for ATP hydrolysis but shows normal
complex assembly (Elfring et al., 1998), displays defects in the PNS
and homeotic transformations. Genome-wide analysis of the Brm
complex in larval salivary glands, has shown that the Brm complex is
associated with nearly all transcriptionally active sites and reduction
of Brm function dramatically reduces the association of RNA
polymerase II with salivary gland chromosomes (Armstrong et al.,
2002). Analysis of the Drosophila Brm complex revealed two different
complexes, BAP (deﬁned by the presence of the SWI1 homolog, Osa),
and PBAP (deﬁned by Polybromo and BAP170) that bind to different
regions on polytene chromosomes (Collins et al., 1999; Moshkin et al.,
2007). Furthermore, Affymetrics microarray analysis of RNAi knock-
down of each complex in S2 cells showed that they direct distinct
transcriptional programs (Mohrmann et al., 2004; Moshkin et al.,
2007). However, what the critical targets of these Brm complexes are
in speciﬁc tissues and how these targets may be modulated during
development is unclear. An insight into this key issue has come from a
genetic screen for modiﬁers of the brahma dominant-negative mutant
phenotype (Armstrong et al., 2005). This study revealed mutations in
genes involved in the Notch and EGF receptor (EGFR)–Ras–MAPK
signaling pathway (Armstrong et al., 2005), suggesting that these
signaling pathways may be targets of Brm or act to modulate the
activity of the Brm complex. Moreover in wing vein development, the
Brm complex was shown to modulate expression of genes in the
EGFR–Ras–MAPK and Decapentapelgic (Dpp/TGFβ) signaling path-
ways (Marenda et al., 2004).
In this study, we investigate the interaction between Gem and the
Brm complex in Drosophila. We show that Gem and Brm form a
complex and genetically interact in an antagonistic manner. We also
demonstrate that Drosophila Gem interacts antagonistically withother members of the Brm–BAP complex during wing development.
Moreover, we provide genetic and biochemical evidence that Brm
promotes, while Gem inhibits, EGFR–Ras–MAPK signalling during
development.
Materials and methods
Fly strains used and genetic analysis
The UAS-brmK804R (brmDN) transgenic ﬂies carry a dominant-
negative form of brahma, which contains a mutation in the ATP-
binding site of the Brm protein that eliminates Brm function in vivo,
but does not affect assembly of the 2-MD Brm complex (Elfring et al.,
1998). Gem was ectopically expressed using a weaker UAS-gem
transgene, UAS-gem43 (Quinn et al., 2001). Other ﬂy stocks used were:
UAS-Snr1 and UAS-Snr1-cdel.3 (Snr1DN) (Zraly et al., 2003), UAS-Osa
(Collins et al., 1999) and en-GAL4, UAS-GFP and C96-GAL4 were
provided by Laura Johnston. All other ﬂy strains were obtained from
Bloomington Stock Center (Bloomington, Indiana) or generated in the
laboratory. For all experiments ﬂies were raised on standard cornmeal
agar food at 25 °C unless otherwise indicated.
UAS-gem dsRNA transgenic ﬂies were generated by amplifying a
500 bp fragment from the gem coding region using speciﬁc PCR
primers (shown below) and ligated as inverted repeats in the pWIZ
plasmid using the AvrII and NheI sites (Lee and Carthew, 2003), and
veriﬁed by DNA sequencing. The UAS-gem-dsRNA line M4 (3rd
chromosome), which resulted in the stronger knockdown of Gem
compared with a second line, M6 (data not shown), was used in this
study.
UAS-brmWT transgenic ﬂies were derived from a construct in pUAST
(Brand et al., 1994) containing the full-length Brm cDNA. The Brm
cDNA from pOT2-Brm (clone LD36356, Berkeley Drosophila Genome
Project) was ampliﬁed by PCR using the primers shown below and
ligated into pUAST using the restriction enzymes NotI and XbaI, and
veriﬁed by DNA sequencing.
UAS-RafGOF contains an N-terminal deletion of the Raf (Phl) coding
sequence from amino acids 2 to 431 and generates a constitutively
activated version of Raf, under the control of the S. cerevisiae UAS
enhancer (Brand et al., 1994; Brand and Perrimon, 1994). To examine
genetic interaction with Brm or Gem and RafGOF, recombinant ﬂies
were generated containing the C96-GAL4 (chromosome 3) with UAS-
RafGOF (chromosome 3) and these ﬂies were crossed either to UAS-GFP
or to UAS-gem or UAS-brmDN or double transgenic ﬂies.
For genetic interactions of adult eyes or wing phenotypes, at least
50 progeny were scored for each cross and representative images for
each genotype are shown. For analysis of adult wings, progeny were
ﬁxed in xylene and wings were dissected and mounted in Canadian





Reverse: 5′ TCCTTCTAGACGCTGTTGTCCTCTTCGC 3′
Brm full-length cDNA




Antibody staining for immunoﬂuorescence
All antibody stainings were carried out in 5% goat serum, PBS, 0.1%
Triton X-100.
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Upstate Cell Signaling Solutions), mouse anti-phospho-ERK (pERK
1:250, Sigma), mouse anti-Cut and anti-22C10 (1:5, Developmental
Hybridoma Bank), rabbit anti-GFP (1:1000, Molecular Probes/Invi-
trogen). Secondary antibodies: anti-rabbit/mouse/rat Alexa 488,
anti-rabbit/mouse/rat Cy3 and anti-rabbit/mouse/rat Cy5 were
used 1:500 (Jackson Immunoresearch).
BrdU labeling
Wing discs from 3rd instar larvae were labeled in Schneider media
with 0.2 mg/ml BrdU (Sigma) at room temperature for 30 min. Wing
discs were ﬁxed for 30 min at 4 °C in 4% formaldehyde PBS, 0.1% Triton
X-100 and BrdU was detected with a mouse anti-BrdU antibody
(Becton Dickinson, 1:50 in 5% goat serum/PBS, 0.1% Triton X-100).
Cy3 donkey anti-mouse (Jackson Immunolaboratories, 1:500 in 5%
goat serum/PBS, 0.1% Triton X-100) was used as a secondary
antibody.
TUNEL assays
Apoptotic cells were detected by TUNEL staining using the in situ
cell death detection kit, TMR Red (Roche).
Microscopy
Bright ﬁeld microscopy was carried out on a Zeiss Axioplan 2 with
Nomarski optics. Images were captured with the SPOT advanced CCD
cooled digital camera. Fluorescence microscopy was carried out using
the Zeiss Axioplan 2 with epi-ﬂuorescence and images captured as
above, or using the Bio-rad MRC-1000 confocal on a Leica DMRBE
microscope excited by a 488 nmexcitation line and a 522DF32 emission
ﬁlter (green), a 568 nm excitation line and a 605DF32 emission ﬁlter
(red), or a 647 nm excitation line and a 680DF32 emission ﬁlter
(far red). Images were captured with the LaserSharp 2000 computer
program. Adobe Photoshop andAdobe Illustratorwere used to generate
the Figures in this paper.
Culturing of S2 cells and expression of BrmWT
D. melanogaster S2 cells stably transfectedwith pMT/V5-His vector
or pMT/V5-His-FLAG tagged Brahma were cultured in Schneider's
insect medium (Sigma) containing 10% heat-inactivated foetal calf
serum and 200 µg/ml hygromycin B at 27 °C. Brahma protein
expression was induced by the addition of 250 µM Cu2+. Cells were
collected by centrifugation, washed in PBS twice and lysed in lysis
buffer (50 mM Hepes, Ph 7.5, 150 mM NaCl, 1% Triton X-100, 0.5 mM
DTT, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 1 mM PMSF), prior
to SDS-PAGE and Western blotting.
Western analysis and immunoprecipitation analysis
Third instar larvae were heat-shocked for 1 h, and then allowed to
recover for either 1 h or 2h before the protein lysates from either
heads or wing discs were prepared. Co-immunoprecipitation was
carried out as previously described (Brumby et al., 2002). Brieﬂy,
protein lysates from third instar larval heads were homogenized in
NTEN buffer with 1 mM PMSF protease inhibitor. For the Brm
immunoprecipitation 330µg of protein was used and 30µg of protein
was run for a Western, to determine the input level, whereas for the
Snr1 immunoprecipitation 220µg of protein was used and 20µg of
protein was run for a Western. The lysates were then incubated with
various antibodies or rabbit pre-immune sera bound to protein G
sephasose beads (GE healthcare). Beads were blocked in 5% goat
serum in NTEN buffer 3 times for 1h total and then washed in NTEN
buffer 3 times for 1h total and a 50/50 slurry was made with thebeads and NTEN buffer. 30 µl of the bead slurry was then bound to the
protein and run on SDS-PAGE gel and immunoblotted.
Primary antibodies used were: polyclonal rat anti-Gem antibody
(1:1000) (Quinn et al., 2001), polyclonal rabbit anti-Brm antibody
(1:1000, from C. Muchardt), polyclonal rabbit anti-Snr1 (1:1000,
from C. Muchardt), monoclonal mouse anti-alpha tubulin (1:10,000,
Cell Biochem), monoclonal mouse anti-pERK (diphosphorylated
ERK1/2/MAPK1/2, 1:10,000, #M8159 Sigma), rabbit anti-pMEK
(pMEK1/2-S217/221, 1:10,000, #9154 Cell Signalling), rabbit anti-
ERK (MAPK, 1:10,000, #4695 Cell Signalling) and rabbit anti-MEK
(MEK1/2, 1:10,000, #9122 Cell Signalling), anti-FLAG (1:1000, M2,
Sigma, F1804). Secondary antibodies used were: anti-mouse HRP
(1:5000, Jackson Immun), anti-rat HRP (1:5000, Jackson Immun),
anti-rabbit HRP (1:5000, Jackson Immun).
Statistical analysis of adult wing phenotypes
Images of adult wings were analyzed using the MetaMorph
program. The total area of wing tissue was found by drawing a line
around the edge of the wing and calculating the total area within. The
area of wing tissuemissingwas found by calculating the estimated area
of wing tissue missing per notch using the samemethod as above, then
adding this together. The total area of wing expected in a wild-type
context was calculated by adding the total area of wing tissue with the
area of wing tissue missing. The percentage of wing tissue missing was
calculated by comparing the total area of wing expected in a wild-type
context with the area of wing tissue missing. The percentage of wing
area missing was compared between genotypes using a One-way
ANOVA and Tukey test using the Graphpad prismprogram version 5.01.
Subsequent graphs were also created using the Graphpad prism
program version 5.01.
Statistical analysis for quantiﬁcation of BrdU, PH3 and TUNEL labeled
cells
In order to quantify the amount of BrdU incorporation, PH3 staining
the pixel intensity in a set area was determined for a minimum of 10
wing discs per genotype. To quantify TUNEL incorporation, the number
of cells that stained for TUNEL in a set area of the wing disc was
counted, using a minimum of 10 wing discs per genotype. The average
number of cells in a given areawas compared between genotypes using
a One-way ANOVA and Tukey test using the Graphpad prism version
5.01. Subsequent graphs were also created using the Graphpad prism
version 5.01.
Method for quantiﬁcation of Western bands for graphs
The Western bands intensity was measured using the ImageJ
program, and then normalized to the intensity value of the α-tubulin
control. These values were then expressed as a fold difference
compared with the wild-type control. Calculations were made using
Microsoft Excel. Graphs were made using GraphPad Prism version 5.01.
To determine the stoichiometry of interactions between Gem, Brm
and Snr1, we measured the relative amount of Gem protein to Brm or
Snr1protein in the immunoprecipitations and theWesterns. The level of
proteins in the inputwasdeterminedbymeasuringband intensityusing
the ImageJprogram. Backgroundwasmeasured froma similar regionon
the gel and subtracted from each band. The ratio of Gem to Brm or Snr1
protein was then determined for each sample. To calculate the
stoichiometry of interaction of Gem with Brm or Snr1, samples over-
expressing BrmWT or Snr1 were used. Since there was a background
band at the size of Gem in the control pre-immune immunoprecipita-
tion in the Snr1 experiment (Fig. 2B(i) lane 3), the amount of Gem
protein in the Snr1 immunoprecipitation was adjusted by subtracting
the band intensity of this background band. Calculations were made
39A. Herr et al. / Developmental Biology 344 (2010) 36–51using Microsoft Excel and Graphs were made using GraphPad Prism
version 5.01.
Results
Drosophila Gem interacts genetically with members of the Brm complex
Wehave previously observed that Gem and Brm genetically interact
in the Drosophilawing and eye (Seo et al., 2005). As Brm functions in a
large protein complex (Dingwall et al., 1995; Papoulas et al., 1998), we
sought to determine whether other Brm complex genes genetically
interacted with Gem. We used the developing wing to examine this,
since interactions were easier to score in this tissue relative to the eye.
We expressed Gem (using the weaker UAS-gem43 transgene (Quinn
et al., 2001) or Brm complex transgenes inwings via the en-GAL4driver,
which is expressed in the posterior compartment of the developing
wing. Expression of Gem produced adult ﬂies with relatively normal
wings (Fig. 1B and B') compared with wild-type ﬂies (Fig. 1A and A').
Ectopic expression of BrmDN led to a loss of the L5 wing vein and loss of
the posterior cross vein (Fig. 1C and C'). Strikingly, ectopic expression of
BrmDN and Gem together using en-GAL4 caused a dramatic develop-
mental defect leading to lethality during the ﬁrst instar larval stage
(data not shown). This phenotype was much stronger than expected if
Gem and BrmDN effects were just additive, indicating that Gem and
BrmDN genetically interact.
We next tested a core member of the Brm complex, snr1 for genetic
interactions with gem in the wing using the en-GAL4 driver. Expression
of a dominant-negative form of Snr1, Snr1-cdel.3 (Snr1DN) (Zraly et al.,
2003), gave a normal wing phenotype when expressed with en-GAL4
(Fig. 1D and D'), but caused a shortening of wing vein L5 when co-
expressed with Gem (Fig. 1E and E'). Thus, gem also genetically
interacts in an antagonistic manner with snr during wing vein
development.
To test whether Osa, a SWI1 homolog, and a component of the
Brm–BAP complex also interacts with Gem, full-length wild-type osa
(UAS-osa) (Collins et al., 1999), was expressed via the en-GAL4 driver.
Expression of osa resulted in a severe wing phenotype, including
ectopic wing veins, blistering of the wing blade and reduced wing size
(Fig. 1F and F'). We reasoned that if Gem acts antagonistically to the
Brm–BAP complex, we would expect that the gain-of-function Osa
phenotypewould be suppressed by co-expression of Gem. Indeed gem
expression strongly suppressed the en-GAL4, UAS-osa wing pheno-
type, although some blistering was still detectable (Fig. 1G and G').
This result showed that interactions between Gem and the Brm
complex are not simply additive, but instead represent a functionally
relevant interaction. Altogether this data shows that Gem interacts
antagonistically with three components of the Brm–BAP complex
(Brm, Snr1 and Osa) in the developing wing.
To validate these interactions in another tissue, we then examined
effects of Gem and Brm complex genes on the embryonic peripheral
nervous system (PNS), which we have previously shown to be affected
by Gem over-expression to result in ectopic neurons (Quinn et al.,
2001). Expression of Gem via the en-GAL4 driver (expressed in the
epithelial cells in the posterior compartment of each parasegment as
well as PNS cells) or the hairy-GAL4 driver (which is expressed in a
similar domain to en-GAL4 in the epidermis, but not in PNS cells),
resulted in ectopic PNS cells as detected by22C10 staining (Supp. Fig. 1),
and reducing Brm complex function resulted in an enhancement of this
effect (data not shown). However, upon closer examination it becameFig. 1. Gem interacts antagonistically with other members of the Brm complex. Images
of adult wings from en-Gal4, UAS-GFP/+ (Wild-type) (A), UAS-gem/en-GAL4, UAS-GFP
(EnNGem) (B), en-GAL4, UAS-GFP/+; UAS-brmDN/+ (EnNBrm-DN) (C), en-GAL4, UAS-
GFP/+; UAS-snr1DN/+ (EnNSnr1-DN) (D), UAS-gem/en-GAL4, UAS-GFP; UAS-snr1DN/+
(EnNSnr1-DN Gem) (E), UAS-osa/en-GAL4, UAS-GFP (EnNOsa) raised at 18 °C (F) and
UAS-gem, UAS-osa/en-GAL4, UAS-GFP (EnNOsa Gem) raised at 18 °C (G). (A–G) 20×
magniﬁcation, and (A'–G') 40× magniﬁcation of the posterior wing margin.
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there was also a loss of neural cells in the PNS, particularly in the lateral
chordotonal neural clusters (lch5) (Supp Fig. 1). Thus, over-expression
of Gem does not induce neural differentiation, aswe originally reported
(Quinnet al., 2001), but rather interfereswith thenormal position of the
PNS neurons. The misplacement of the PNS neurons due to gem over-
expression and the enhancement of this by brmDNmay be due to effects
on the cell cycle, cell morphology or on signaling pathways affecting cell
movement.
Gem and Brm physically interact in vivo
To test whether Gem and Brm complex proteins physically interact
in Drosophila, we performed co-immunoprecipitation analysis with
extracts from larval heads (which includes brains and eye, leg, haltere
and wing imaginal discs) prepared from either wild-type larvae
(hsp70-GAL4 control), or larvae over-expressing the BrmWT protein
(see Materials and methods), the Brm complex protein, Snr1 (Zraly et
al., 2003), or Gem under control of the hsp70-GAL4 driver (see
Materials and methods). When an anti-Gem antibody was used to
immunoprecipitate Gem from Drosophila, a protein band that
migrated at ∼30 kDa, consistent with the molecular weight expected
for Gem (Quinn et al., 2001), was detected (Fig. 2A lane 1, Fig. 2B lane
1). When anti-Brm antibody was used to immunoprecipitate Brm
from wild-type extracts (hs-GAL4, Fig. 2A(i) lane 2) a ∼30 kDa band
was also detected with the anti-Gem antibody, although Brm itself
was below detection levels in these extracts. This result shows that a
complex forms between endogenous Gem and Brm proteins in
Drosophila wing discs. The immunoprecipitation of Gem was speciﬁc,
since this band was not detected in the control immunoprecipitations
using pre-immune serum (Fig. 2A(i) lane 5). When BrmWT protein
was over-expressed in larval tissues, increased levels of Gem protein
were observed in the immunoprecipitate (Fig. 2A(i) lane 3, quantiﬁed
in 2A(iii)). Gemwas also immunoprecipitated with Snr1 in wing discs
over-expressing Snr1 (Fig. 2A(i) lane 4, Fig. 2B(i) lane 2). In this
experiment, a protein ∼30 kDa was detected in the control immuno-
precipitation (Fig. 2B(i) lane 3), but at lower levels compared with
that in the Snr1 immunoprecipitate (Fig. 2B(i) lane 2, quantiﬁed in
Fig. 2B(iii)). Interestingly, in the reverse immunoprecipitation, with
the Gem antibody from extracts over-expressing Gem, the Brm or
Snr1 proteins were not detectable (Fig. 2A(i) lane 1, Fig. 2B(i) lane 1).
This may be due to the relatively low level of Brm and Snr1 proteins
present in the input and the detection of these proteins in the anti-
Gem immunoprecipitates being beyond the sensitivity of the
antibodies, or alternatively to the masking of Gem antibody epitopes
by the interaction of Gem with Brm complex proteins. To determine
the amount of Gem interacting with Brm and Snr1, we compared the %
of Gem to Brm or Snr1 in the immunoprecipitations relative to the
ratio of Gem to Brm or Snr1 in the input (Supp. Table 1). From the
BrmWT or Snr1 over-expression samples, we calculated that ∼46% of
total Gem immunoprecipitated with Brm and ∼38% of total Gem was
immunoprecipitated with Snr1 (see Materials and methods). Further
analysis is needed to conﬁrm this stoichiometry in the interaction of
Brm and Snr1 proteins with Gem. Taken together, this data conﬁrms
and extends the results from the Xenopus system, showing that Brm,
as well as another Brm complex component, Snr1, form complexes
with Gem in Drosophila larval tissues.
BrmDN does not enhance the effect of Gem on cell proliferation or survival in
the developing wing
To determine the cellular basis for the interaction of Gem with
compromised Brm function, we ﬁrst explored whether these proteins
may exert their effect by modulating cell proliferation. We have
previously shown that over-expression of Gem inhibits DNA replication
and leads to arrest in mitosis in the embryo (Quinn et al., 2001). Wetherefore examined whether expression of BrmDN affects the cell cycle
and whether co-expression of BrmDN with Gem could enhance the
effects of Gem on the cell cycle in wing discs. As shown in Fig. 3C,
expression of the Gem43 transgene via the heat-shock inducible hsp70-
GAL4 driver resulted in a slight reduction of S-phase cells, as assayed by
BrdU labeling in the wing disc compared with the control (Fig. 3A),
while BrmDN expression showed a slight increase in S-phase cells
(Fig. 3B). However, when expressed with Gem, BrmDN did not decrease
the number of S-phase cells (Fig. 3B,M), aswould have been expected if
BrmDNwas enhancing the Gem phenotype through increasing the G1 to
S-phase blockage. Gem expression also resulted in a slight increase in
the number of mitotic ﬁgures, as revealed by phospho-Histone H3
(PH3) staining (Fig. 3G compared with 3E, and quantiﬁed in 3N), and in
cell death, as assayed by TUNEL (Fig. 3K compared with 3I, and
quantiﬁed in 3O) as expected based on previous ﬁndings (Quinn et al.,
2001). Expression of BrmDN alone had little effect on mitoses or cell
survival (Fig. 3F, J). Importantly, co-expression of BrmDN with Gem did
not enhance these effects on mitosis or cell death (Fig. 3H, L and
quantiﬁed in 3N, O), as would be expected if BrmDN was acting with
Gem on the cell cycle or cell death. Taken together, these results show
that BrmDN does not enhance the effect of Gem on cell proliferation or
survival in the developing wing. Therefore, we conclude that this
genetic interaction between Gem and BrmDN must be occurring by
another mechanism.
Gem and BrmDN act antagonistically on EGFR–Ras–MAPK pathway
signaling during wing development
Since expression of Gem in the background of compromised Brm
function led to defects in wing vein development (Fig. 1), we sought
to determine whether Brm and Gemmight function to affect signaling
pathways required for wing vein speciﬁcation (De Celis, 2003;
Guichard et al., 1999; Sotillos and De Celis, 2005). While the EGFR,
Notch and Dpp signaling pathways are important for wing vein
speciﬁcation, we focused our attention on the EGFR signaling pathway
in this study. The EGFR pathway plays important roles in many stages
during Drosophila development (Baker and Yu, 2001; Tepass et al.,
2002). During wing development of the Drosophilawing imaginal disc
at the third instar larval stage, EGFR signaling is activated at the
dorsal–ventral and anterior–posterior boundaries in the wing disc
primordial (Brentrup et al., 2000; Crozatier et al., 2002). In Drosophila,
the EGFR signaling pathway, acts through the Ras–MAPK signaling
pathway to activate key target genes important for cell proliferation
and wing vein formation (Karim and Rubin, 1998; O'Keefe et al.,
2007a,b; Prober and Edgar, 2000).
To investigate whether EGFR–Ras–MAPK signaling was affected by
brmDN and gem expression, we examined their effect on these
pathways in the wing imaginal disc. Since co-expression of brmDN
and gem via the en-GAL4 driver was early larval lethal, we used C96-
GAL4 to drive expression of these genes. This driver is expressed in the
dorsal–ventral boundary of the wing pouch, which gives rise to adult
wing margin. The dorsal–ventral boundary of the larval wing disc
coincides with the zone of non-proliferating cells (ZNC), where cells
are arrested in either G1- or G2-phase (Johnston and Edgar, 1998).
Therefore, using this driver provided the additional advantage of
being able to examine the effects of Gem and Brm expression on the
EGFR–Ras–MAPK signaling pathway in the wing disc independent of
effects on the cell cycle. We have previously shown that C96-GAL4-
induced expression of brmDN and gem alone does not affect the adult
wing, while co-expression of these genes leads to wing notching (Seo
et al., 2005).
To monitor the effects of brmDN and gem on the EGFR–Ras–MAPK
pathway, we used an antibody to activated Erk/MAPK/Rolled
(phospho-ERK, pERK). We also analyzed expression of the Notch
pathway target, Cut, which is expressed in the dorsal–ventral
boundary (Johnston and Edgar, 1998). The wild-type expression of
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alone (Fig. 4B, C, F and G, compared with 4A and E), however, co-
expression of brmDN and gem caused a signiﬁcant decrease in pERK
staining (Fig. 4D), whilst Cut remained unaffected (Fig. 4H). This data
shows that Gem and BrmDN interfere with EGFR–Ras–MAPK pathway
signaling, but do not affect expression of the Notch target, Cut, at the
dorsal–ventral boundary during wing development.
To conﬁrm these results, we investigated the reverse context by
knocking down Gem and expressing wild-type Brm (BrmWT). To
reduce the levels of Gem, we generated transgenic ﬂies containing a
UAS-gem RNA interference (RNAi) construct, using the pWiz vector
(Lee and Carthew, 2003; Narbonne-Reveau et al., 2008). In order to
verify that the Gem-RNAi constructs were capable of knocking down
Gem protein levels in vivo, we expressed gem-RNAi in third instar
larval wing discs with en-GAL4. Ectopic expression of two indepen-
dent insertions led to a clear reduction in Gem staining cells when
compared with the anterior part of the wing disc (Supp. Fig. 2, and
data not shown). To ectopically express Brm, we generated UAS-
brmWT transgenic ﬂies, and showed that the transgene was expressed
by Western analysis after heat-shock induction using the hsp70-GAL4
driver (Supp. Fig. 3).
To determine whether gem-RNAi or brmWT could up-regulate the
Ras pathway signaling we used en-GAL4 to express these genes in the
posterior compartment of the wing disc, so that we could compare
effects on pERK staining in the posterior compartment with that of the
anterior compartment of the same wing disc. Expression of gem-RNAi
via en-GAL4 was mostly pupal lethal, alone as well as together with
brm transgenes, while enNbrmWT alone or together with gem had no
apparent effect on the adult wing phenotype (data not shown). In
third instar larval wing discs, ectopic expression of gem-RNAi or brmWT
alone did not affect the levels of pERK staining relative to the anterior
compartment or to wild-type (Fig. 5C and B, compared with A).
However, co-expression of gem-RNAi with brmWT resulted in a slight
increase in pERK staining in the posterior compartment relative to the
anterior compartment and compared with wild-type discs (Fig. 5D
compared with A). We also analyzed the effect of expressing brmWT
together with gem in larval wing discs. Using the en-GAL4 driver,
expression of gem alone resulted in a slight decrease in pERK staining
(Fig. 5E), however, expression of gem and brmWT together restored
pERK levels when compared with the anterior part of the disc or
expression of gem alone (Fig. 5F, compare with E).
Interestingly, using the en-GAL4 driver (in contrast to the
apparently weaker C96-GAL4 driver; Fig. 4) expression of brmDN
alone caused a dramatic reduction in pERK levels relative to the
anterior compartment or to wild-type discs (Fig. 5G compared with
A). This decrease in pERK levels by expression of BrmDN, is consistent
with the requirement of EGFR–Ras–MAPK signaling for wing vein
formation and that reducing Brm function leads to a loss of wing veins
(Fig. 1C). To examine the interaction of endogenous Gem with BrmDN
in this effect on pERK, we examined whether reducing Gem levels
could suppress the reduction of pERK levels by BrmDN. Indeed,
expression of gem-RNAi and brmDN together suppressed the decreaseFig. 2. Gem and components of the Brm complex form a protein complex in vivo. (A) Gem, Brm
hsp70-GAL4/+ ; UAS-brmWT/+ (hsNbrmWT), hsp70-GAL4/UAS-gem43 (hsNgem) and hsp70-G
larvae were immunoprecipitated with anti-Gem antibody (lane 1), anti-Brm antibody (lanes
control) and immunoblottedwith anti-Brm antibody (row 1) or anti-Gem antibody (row 2). Al
protein (∼30 kDa) was detected when immunoprecipitated with Gem (lane 1), Brm (lane 2 an
detected when immunoprecipitated with the Brm (lane 3) or Snr1 (lane 4) antibodies. (ii) S
330 µg), were run on aWestern and immunoblotted with anti-Brm antibody (row 1), anti-Gem
when gemwas over-expressed using the hsp70-GAL4 driver, and Brm protein was higher when
immunoprecipitations versus input (see Materials and methods). (B) Gem and Snr1 form a
(hsNgem), hsp70-GAL4/+ ; UAS-Snr1/+ (hsNSnr1) or hsp70-GAL4/+ (hs-Gal4) heat-shocked
(lane 1), anti-Snr1 (lane 2) or rabbit pre-immune serum (lane 3, as a negative control) and imm
but intervening marker tracks have been removed. The Gem protein (∼30 kDa) was detected w
detected when immunoprecipitated with the Snr1 (lane 2) antibody. (ii) Samples from the p
immunoblottedwith anti-Snr1 (row 1), anti-Gem (row 2) or anti-α-Tubulin (row 3). Snr1 prot
that, due to high levels of the Snr1 protein in this track, the band is whitened out), and Gem pro
protein levels in the immunoprecipitations versus input. In A(i, ii) and B (i, ii) +/– refers to ein pERK staining seen with brmDN alone (Fig. 5H compared with G).
Collectively, these results show that Gem and Brm act upon the EGFR–
Ras–MAPK pathway in an antagonistic manner, with Brm promoting
EGFR–Ras–MAPK signaling and Gem opposing this.
Gem and Brm genetically interact with a Raf (MAPKKK) gain-of-function
phenotype in the wing
To further investigate the relationship between gem and brm and
EGFR–Ras–MAPK signaling, we generated ﬂies that expressed an
activated allele of the MAPKKK/Drosophila Raf (RafGOF (Brand and
Perrimon, 1994)), via the C96-GAL4 driver in the dorsal–ventral
compartment in the developing wing. C96-GAL4-driven expression of
activated alleles of the EGF receptor result in wing notching and wing
vein truncations (Settle et al., 2003), presumably due to aberrant
differentiation or cell death. Similarly, we found that C96-GAL4-driven
RafGOF resulted in wing notching and truncation of the veins (Fig. 6A
(i)). When expressed alone via the C96-GAL4-driver gem or brmDN had
no signiﬁcant effect on the adult wing phenotype, while co-expression
of gem and brmDN resulted in slight wing notching (Seo et al., 2005).
Expression of gem or brmDN alone in the C96NRafGOF background did
not signiﬁcantly affect the C96NRafGOF notched wing phenotype
(Fig. 6A(ii, iv) compared with 6A(i)). However, halving the dosage
of brm (using the brm2 null allele), showed a signiﬁcant suppression of
the C96NRafGOF notchedwing phenotype (Fig. 6A(iii) and quantiﬁed in
6A(vii)). Importantly, co-expression of gem and brmDN, or halving the
dose of brm, in the C96NRafGOF background resulted in a signiﬁcant
suppression of the notched wing phenotype (Fig. 6A(v, vi) and
quantiﬁed in 6A(vii)). Thus, although reducing Brm function alone
can repress the effects of RafGOF on wing development, up-regulation
of Gem together with compromised Brm function can more fully
abrogate these effects.
We then tested whether decreasing Gem function could enhance
the C96NRafGOF notchedwing phenotype. Reducing the dosage of Gem,
using two strong alleles, gemk03202b or gemk14019 in the C96NRafGOF
background, caused a signiﬁcant worsening of the RafGOF notched
wing phenotype (Fig. 6B(ii–iii) compared with 6B(i), and quantiﬁed
in 6B(iv)). Thus the RafGOF notched wing phenotype is sensitive to the
levels of Gem. Taken together, these results show that when Raf–
MAPK signaling is up-regulated the Gem and Brm levels canmodulate
the phenotypic effects of RafGOF. Furthermore, these data show that,
consistent with the results described above, Gem and Brm act
antagonistically on Raf–MAPK signaling.
Gem and Brm dominantly modify the rough eye phenotype due to
expression of an activated allele of the EGFR in the eye
To explorewhether Gem and Brm have physiological effects on the
EGFR–Ras–MAPK signaling pathwaymore generally duringDrosophila
development, we examined their effects on EGFR signaling during eye
development. To address this, we utilized a dominant activated allele
of the EGFR, ElpB1, which produces a small and rough eye phenotypeand Snr1 interact in vivo. (i) Protein lysates from the heads of hsp70-GAL4/+ (hs-Gal4),
AL4/+ ; UAS-Snr1/+ (hsNSnr1) heat-shocked (1h heat shock, 1h recovery) third instar
2 and 3), anti-Snr1 antibody (lane 4) or rabbit pre-immune serum (lane 5, as a negative
l tracks are from the same gel, but interveningmarker tracks have been removed. The Gem
d 3) or Snr1 (lane 4) antibodies. When over-expressed, the Brm protein (∼180 kDa) was
amples from the protein lysates, used for immunoprecipitations (30 µg compared with
antibody (row 2) or anti-α-Tubulin antibody (row 3). Gem protein was more abundant
brmWTwas over-expressed using the hsp70-GAL4 driver. (iii) Relative protein levels in the
protein complex in vivo. (i) Protein lysates from the heads of hsp70-GAL4/UAS-gem43
(1h heat shock, 1h recovery) third instar larvae were immunoprecipitated with anti-Gem
unoblotted with anti-Snr1 (row 1) or anti-Gem (row 2). All tracks are from the same gel,
hen immunoprecipitated, Gem (lane 1) or Snr1 (lane 2) antibodies. The Snr1 protein was
rotein lysates, used for the immunoprecipitations (20 µg compared with 220 µg), were
ein wasmore abundantwhen Snr1was over-expressed using the hsp70-GAL4 driver (note
tein was higher when gemwas over-expressed using the hsp70-GAL4 driver. (iii) Relative
ctopic expression of the protein.
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Fig. 3. The affect of Gem and Brm on the cell cycle and cell death. Confocal images of third instar larval wing imaginal discs which were heat shocked for 1h and allowed to recover for
1h of the following genotypes: hsGAL4/+ (A, E, I); hsGAL4/+; UAS-brmDN/+ (hsNbrmDN) (B, F, J); hsGAL4/UAS-gem (hsNgem) (C, G, K); hsGAL4/UAS-gem; UAS-brmDN/+ (hsNgem
brmDN) (D, H, L). Discs were either labeled with BrdU (A, B, C, D), PH3 (E, F, G, H), or TUNEL (I, J, K, L). Over-expression of gem (hsNgem; C) or gem and a dominant-negative form of
brm (hsNgem brmDN; D) resulted in a signiﬁcantly decreased amount of BrdU incorporation compared with wild-type (hsGAL4/+; A), as shown in a graph (M) representing the
average pixel intensities of each genotype (nN10). The over-expression of gem (hsNgem) also resulted in signiﬁcantly more PH3 staining (G) and TUNEL staining (K) compared with
wild type-(hsGAL4/+) (E, I), also shown in graphs representing the average pixel intensities of each genotype for PH3 (N) or average number of TUNEL stained cells (O) (nN10). The
hsNgem induced increase in PH3 and TUNEL staining was somewhat decreased by BrmDN co-expression (H, L, N, O). Error bars=standard error of themean. *=signiﬁcantly different
compared with the control using a One-Way ANOVA and Tukey test.
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decreased numbers of photoreceptor clusters formed (Baker and
Rubin, 1989; Baker and Rubin, 1992; Baonza et al., 2001; Zak and
Shilo, 1992). We expressed the BrmDN genomic construct or reduced
the dosage of brm or gem in the EGFRElpB1 background. The small rough
eye phenotype of EGFRElpB1/+ was suppressed by expression of the
BrmDN gene (Fig. 7C) or by reducing the dose of brm, using the brm2
allele (Fig. 7D). Conversely, reducing the dose of gem, using the
gemk03203b allele enhanced the EGFRElpB1/+ small rough eye pheno-
type (Fig. 7E). These results are consistent with the notion that
reducing Brm activity can reduce EGFR–Ras–MAPK signaling, whilereducing Gem activity can increase signaling through this pathway.
Thus, the modulation of EGFR–Ras–MAPK signaling by Brm and Gem
occurs similarly in the eye disc as it does in the wing disc (Figs. 4
and 5). The modulation of the ElpB1 phenotype by Gem and Brm we
observed occurs mostly by affecting the size of the eye, which can
reﬂect changes in tissue growth, as well as differentiation. Since the
ElpB1 mutation affects photoreceptor cluster formation, cell prolifer-
ation and survival in the developing eye (Baker and Rubin, 1989;
Baker and Rubin, 1992; Baonza et al., 2001; Zak and Shilo, 1992),
further studies are required to determine the precise cellular effects of
Brm and Gem on EGFR signaling in the eye.
Fig. 4. Gem and Brm act antagonistically on the EGFR/Ras/MAPK pathway, but not the Notch pathway. Confocal images of third instar larval wing imaginal discs of the following
genotypes C96-GAL4, UAS-GFP/+ (Wild-type) (A, A', E, E'), UAS-gem/+; C96-GAL4, UAS-GFP (C96NGem) (B, B', F, F'), UAS-brmDN/C96-GAL4, UAS-GFP (C96NBrm-DN) (C, C', G, G') or
UAS-gem/+; UAS-brmDN/C96-GAL4, UAS-GFP (C96NGem Brm-DN) (D, D', H, H') were stained with antibodies to pERK/MAPK (A–D), or the Notch signaling pathway target, Cut (E–
H). (A'–D') show a merge between pERK (red) and GFP (green) and (E'–H') show a merge between cut (red) and GFP (green). Note the reduction of pERK/MAPK staining upon gem
and brmDN co-expression (arrow in D).
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To further explore the effect of Gem and Brm on the EGFR–Ras–
MAPK pathway, we assayed the effect of expressing Gem and BrmDN
by heat-shock induction using the hsp70-GAL4 driver on pERK and
total ERK levels in larval wing discs by Western analysis (Fig. 8A). In
agreement with our immuno-ﬂuorescence analysis, co-expression of
Gem and BrmDN reduced pERK levels (by ∼50%), however ERK levels
were similar to the control in all samples. Expression of Gem or BrmDN
alone did not result in decreased pERK or ERK levels (Fig. 8A). The
amount of pERK slightly increasedwhen brmDNwas over-expressed in
this experiment although this was not consistent in other experi-
ments (data not shown). Thus, in a background compromised for Brm
function, expression of Gem alters ERK activation without affecting
total ERK protein levels.
We also examined the effect of over-expression of wild-type Brm
(BrmWT) alone in Drosophila S2 (hemocyte-derived) tissue culture
cells (seeMaterials andmethods) or when expressed in wing discs via
the hsp70-GAL4 driver (Fig. 8B, C). In S2 cells, we found that BrmWT
expression resulted in an increase in pERK levels by 1.5 fold (Fig. 8B),
without effects on ERK or Raf (MAPKKK) levels (Fig. 8B). Likewise, in
wing disc samples over-expression of wild-type Brm alone increased
pERK 1.45 fold (Fig. 8C). These results are consistent with theincreased pERK levels observed when brmWT and gem-RNAi were co-
expressed via the en-GAL4 driver (Fig. 5G).
Gem and BrmDN cooperate to reduce MEK (MAPKK) levels
Next we sought to investigate themechanism bywhich BrmDN and
Gem cooperate to decrease pERK levels. Using the same system of
heat-shock induction of BrmDN, Gem or both proteins in wing discs,
described above, we analyzed the effect of these protein on activation
of MEK (MAPKK/Sor), the kinase that phosphorylates and actives ERK
(by using the pMEK antibody), and on total MEK levels. As shown in
Fig. 9, while expression of BrmDN or Gem alone resulted in slight
decreases in MEK or pMEK levels, together they lead to a substantial
reduction of both pMEK and MEK levels (to ∼40% relative to the
control). Thus, BrmDN and Gem cooperate to decrease MEK protein
levels, consistent with the reduced pERK levels observed (Figs. 4, 5
and 8).
Discussion
In this study, we have analyzed the interaction of Drosophila Gem
with the Brm complex in cell proliferation, apoptosis and differenti-
ation during development. We show that Brm and Snr1 can form a
Fig. 5. Knockdown of Gem and over-expression of BrmWT increases pERK levels. Confocal images of third instar larvae wing discs from en-GAL4, UAS-GFP/+ (Wild-type) (A, A'),
en-GAL4, UAS-GFP/+; UAS-brmWT/+ (EnNBrm-WT) (B, B'), en-GAL4, UAS-GFP/UAS-dsRNA gem (EnNGem-i) (C, C'), en-GAL4, UAS-GFP/UAS-dsRNA gem; UAS-brmWT/+ (EnNGem-i
Brm-WT) (D, D'), en-GAL4, UAS-GFP/UAS-gem (EnNGem) (E, E'), en-GAL4, UAS-GFP/UAS-gem; UAS-brmWT/+ (EnNGem Brm-WT) (F, F'), en-GAL4, UAS-GFP/+; UAS-brmDN/+ (EnNBrm-
DN) (G, G') or en-GAL4, UAS-GFP/UAS-dsRNA gem; UAS-brmDN/+ (EnNGem-i Brm-DN) (H, H'). Discs were stained with antibodies to pERK/MAPK in (A–H) and (A'–H') show a merge of
pERK (red) and GFP (green).
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interacts with Brm, Snr1 and osa. Since Osa is the deﬁning member of
the Brm–BAP complex (Collins et al., 1999; Moshkin et al., 2007),
these results implicate the Brm–BAP complex in the interaction with
Gem. Our studies also revealed in three different ways that Brm acts
antagonistically to Gem upon the EGFR–Ras–MAPK signaling path-
way: ﬁrstly, reducing Brm function cooperates with Gem to decrease
activation of ERK (pERK) in the developing wing disc; secondly, over-
expressing Brm together with Gem knockdown results in increased
pERK levels in the developing wing; and thirdly modulating Brm or
Gem function modiﬁes the wing and eye phenotypes of gain-of-
function alleles in the EGFR–Ras–MAPK signaling pathway. Finally, we
show that the mechanism by which Gem cooperates with compro-
mised Brm function to decrease EGFR–Ras–MAPK signaling is by
decreasing MEK (MAPKK) levels, consistent with the observed
reduction in pERK levels.The interaction of Gem with the Brahma complex
We have shown that Gem genetically interacts in an antagonistic
manner with Brm and two other members of the Brm complex, Osa
and Snr1 (Fig. 1). These interactions are consistentwith amodelwhere
Gem inhibits, or is inhibited by Brm activity duringwing development.
The precise manner by which this interaction occurs is yet to be
determined, however, our observation that Gem co-immunoprecipi-
tates with Brm and Snr1 in vivo (Fig. 2), suggests that the antagonistic
genetic interactions are likely to be mediated through physical
association of Gemwith the Brm complex. Further studies are required
to determine whether the interaction between Drosophila Gem and
Brm are direct, and whether Gem also physically interacts with other
members of the Brm complex. Given our observation that Gem
genetically interacts with Osa (Fig. 1), and Osa deﬁnes the Brm–BAP
complex (Collins et al., 1999; Moshkin et al., 2007), it is likely that this
Fig. 6. Gem and Brm genetically interact with RafGOF in the wing. A Images of adult wings of the following genotypes: (i) C96-GAL4, UAS-RafGOF/+ (C96NRafGOF), (ii) UAS-gem43/+;C96-GAL4, UAS-RafGOF/+ (C96NRafGOF gem), (iii) C96-GAL4,
UAS-RafGOF/brm2 (C96NRafGOF brm2), (iv) C96-GAL4, UAS-RafGOF/UAS-brmDN (C96NRafGOF brmDN), (v) UAS-gem43/+;C96-GAL4, UAS-RafGOF/brm2 (C96NRafGOF gem brm2), (vi) UAS-gem43/+;C96-GAL4, UAS-RafGOF/UAS-brmDN (C96NRafGOF
gem brmDN). (vii) A graph representing the percentage of wing area missing due to the notching for each genotype. The percentage of wing area missing in C96NRafGOF (i) wings is signiﬁcantly reduced when gem and brmDN are co-expressed
(vi) or upon halving the dose of brm (v). There was also a signiﬁcant decrease in the C96NRafGOF wing area missing when halving the dosage of brm (iii). This was further suppressed when gemwas also expressed (v). The suppression of the
C96NRafGOF notching phenotype is also signiﬁcant when comparing the over-expression of gem and brm2 together (v) versus brm2 alone (iii). B Images of adult wings of the following genotypes: (i) C96-GAL4, UAS-RafGOF/+ (C96NRafGOF), (ii)
gemk03202b/+; C96-GAL4, UAS-RafGOF/+ (C96NRafGOF gemk03202b), (iii) gemk14019/+; C96-GAL4, UAS-RafGOF/+ (C96NRafGOF gemk14019). (iv) Quantiﬁcation of wing tissue loss for each genotype (see Materials and methods). The percentage of
wing areamissing in C96NRafGOF (i) wings was signiﬁcantly increased when the dosage of gemwas decreased using the alleles, gemk03202b (ii) or gemk14019 (iii). Error bars=standard error of themean. *=signiﬁcantly different compared with















Fig. 7. Gem and Brm genetically interact with an activated allele of the EGFR in the eye. Images of male adult eyes of the following genotypes: (A) Canton-S (Wild Type),
(B) ElpB1/+, (C) ElpB1/+; brmDN/+, (D) ElpB1/+; brm2/+, (E) ElpB1/+; gemk03202b/+.
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needed to directly determine whether the deﬁning components of the
PBAP complex may also genetically and physically interact with Gem.
In Xenopus, Brg1 acts antagonistically with Xenopus Geminin and
inﬂuences its neuralization function, which has been mapped to the
N-terminal domain (Kroll et al., 1998; McGarry and Kirschner, 1998;
Seo et al., 2005). However, in Drosophila, we have now shown that
Gem does not induce neurogenesis in the developing embryo, but
instead appears to result in a misplacement of peripheral nervous
system cells (Supp. Fig. 1). In conﬁrmation of this result, we have
found that expression of the N-terminal domain of Drosophila Gem,
which in Xenopus Geminin is capable of affecting neural differentia-
tion (Kroll et al., 1998), has no affect on Drosophila embryonic or eye
imaginal disc neural patterning (data not shown). By contrast,
expression of a C-terminal fragment of Drosophila Gem, which
mediates the DNA replication inhibitory function of Gem, also resulted
in misplaced neural cells during embryogenesis (data not shown).
This C-terminal fragment of Drosophila Gem also genetically interacts
with BrmDN (data not shown), however further experiments are
necessary to determine if the binding between Drosophila Gem and
Brm also requires acidic amino acids in the C-terminal tail, as occurs in
Xenopus (Seo et al., 2005).
Regulation of EGFR–Ras–MAPK pathway signaling by the Brm complex
and Gem
Surprisingly, we found that the enhancement of the phenotypic
effects due to compromised Brm function by Gem over-expression, did
not occur by BrmDN enhancing Gem's effect on the cell cycle or cell
death, but instead it is likely that Gem and BrmDN interact by affecting
differentiation of wing vein cell fate (Figs. 2 and 3). Indeed, we found
that the EGFR–Ras–MAPK signaling pathway, important for wing vein
speciﬁcation (De Celis, 2003), was modulated by Brm and Gem. We
found co-expression of gem and brmDN inhibited EGFR–Ras–MAPK
pathway signaling, as measured by phosphorylated Erk/MAPK/Rolled
(pErk) staining (Fig. 4). Furthermore, expression of BrmDN alone
decreased EGFR–Ras–MAPK pathway signaling (Fig. 5G), whereas
increasing BrmWT expression promoted EGFR–Ras–MAPK pathway
signaling (Fig. 8B, C). These results are consistent with the genetic
interaction of the Ras pathway mutant, vein, with the BrmDN eye
phenotype observed in the study of Armstrong et al. (2005), which
indicates that BrmDN expression compromises EGFR–Ras–MAPK signal-
ing. In addition, a recent study (Terriente-Felix and de Celis, 2009), has
also shown that the Brm–BAP complex is linked to EGFR signaling. Theyshowed that osamutants were able to suppress RasV12 or activated ERK
(ERKSEM) over-expression wing phenotypes. This genetic interaction is
in agreementwith our results that reducingBrm function alonewas able
to suppress phenotypes due to up-regulation of EGFR signaling (Figs. 6A
(iii) and 7C, D). However, Terriente-Felix and de Celis (2009) found that
in osamutants pERK levels were variable, and therefore concluded that
the Brm–BAP complex was required for sustained EGFR–Ras–MAPK
signaling. They found that EGFR pathway targets, rhomboid (encoding a
positive regulator of EGFR activity) and argos (encoding an inhibitory
ligand of EGFR), were reduced in Osa-depleted cells, and therefore
hypothesized that the Brm–BAP complex acts on the chromatin of these
EGFR targets tomodulate their expression. They argued that the effect of
Osa depletion on the expression of these EGFR feedback targets and the
opposing effects of Argos and Rhomboid on EGFR signaling, could
explain the variable levels of pERKobserved. In our analysis, the effect of
BrmDN expression via the en-GAL4 driver on pERK was much more
consistently reduced (Fig. 5G), thanwasobservedbyTerriente-Felix and
de Celis (2009). It is possible that the variable effects that they observed
may be due to a lower knock downof Brm–BAP complex activity in their
systemrelative to ours. Indeed, in situationswhereBrmactivitymay not
be knocked down as strongly in our experiments (i.e. when BrmDN is
expressed via the C96-GAL4 or the hsp70-GAL4 drivers), we did not
observe a decrease in pERK levels (Fig. 4C and 8A). However, we
observed that over-expressionof BrmWT(via the enorhsp70drivers) led
to increased pERK levels (Fig. 5F and 8B, C). Although we have not
looked at rhomboid or argos expression in our study, our results are
compatible with their hypothesis that the Brm–BAP complex could act
upon the chromatin of these andother EGFR targets to regulate the EGFR
signaling pathway.
Our studies have shown that Gem and Brm affect pERK levels,
and genetically interact with EGFRElp and Raf/MAPKKKGOF pheno-
types (Figs. 4–8), indicating that Gem and Brm act antagonistically
on the EGFR–Ras–MAPK pathway. Moreover, we have shown that
expression of Gem in a Brm compromised background resulted in
decreased MEK levels, thereby explaining the decreased pERK in cells
expressing Gem and BrmDN. The precise mechanism by which Brm
and Gem effect MEK levels will require further analysis, however,
given the role of Brm in chromatin remodeling and transcriptional
regulation of a large number of genes and the ability of Gem to
interact with various transcription factors in other organisms, it is
likely that the effect occurs at the level of MEK transcription. Whether
up- or down-regulation of Brm can by itself affect MEK levels in
situations where pERK levels are also affected will also require further
investigation.
Fig. 8. Co-expression of Gem and BrmDN reduces pERK activity. A (i) Protein lysates of wing discs of hsp70-GAL4/+ (w1118, lane 1), hsp70-GAL4/+ ; UAS-brmDN/+ (brmDN, lane 2),
hsp70-GAL4/UAS-gem43 (gem, lane 3) and hsp70-GAL4/UAS-gem43; UAS-brmDN/+ (brmDN gem, lane 4) heat shocked (1h heat shock, 2h recovery) third instar larvae were run on a
Western and immunoblotted with phospho-ERK antibody (pERK, row 1), ERK antibody (ERK, row 2) and α-Tubulin antibody (Tubulin, row 3). The amount of pERK was similar
when brmDN or gem was over-expressed, but coexpression of brmDN and gem resulted in a decrease in pERK levels. The amount of ERK was similar when either brmDN, gem or both
were over-expressed in the wing tissue. (ii) Quantiﬁcation of band intensities (see Materials and methods). B (i) Drosophila S2 cells transfected with pMT/V5-His vector (Vec) or
pMT/V5-His-FLAG-tagged brm (FLAG-brm) were incubated with 250 µM Cu2+. Lysates were prepared and subjected toWestern blotting with antibodies against FLAG to detect Brm
(row 1), phospho-ERK (row 2), ERK (row 3) and Raf (row 4). Cells over-expressing ectopic brm increased the levels of activated phospho-ERK relative to vector control cells. The
levels of ERK and Raf were similar between vector control and cells expressing ectopic brm. (ii) Quantiﬁcation of band intensities. The levels of ERK and Raf were similar between
control and cells over-expressing brm. C (i) Protein lysates of hsp70-GAL4/+ (w1118, lane 1) and hsp70-GAL4/+; UAS-brmWT/+ (brmWT) heat shocked (1h heat shock, 2h recovery)
third instar larvae heads were run on a Western and immunoblotted with phospho-ERK antibody (pERK, row 1) and α-Tubulin antibody (row 2). The amount of pERK increased
when a wild-type brm was over-expressed compared with the control. (ii) Quantiﬁcation of band intensities. In A(i) and C(i) +/– refers to ectopic expression of the protein.
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Fig. 9. (A) GemandBrmDN cooperate to reduceMEK levels. Protein lysates ofwing discs of hsp70-GAL4/+ (w1118, lane 1), hsp70-GAL4/+ ; UAS-brmDN/+ (brmDN, lane 2), hsp70-GAL4/UAS-
gem43 (gem, lane 3) and hsp70-GAL4/UAS-gem43; UAS-brmDN/+ (brmDN gem, lane 4) heat shocked (1h heat shock, 2h recovery) third instar larvae were run on a Western and
immunoblotted with phospho-MEK antibody (pMEK, row 1), MEK antibody (MEK, row 2) or α-Tubulin antibody (Tubulin, row 3). The levels of both MEK and pMEKwere reduced when
both gem and brmDN (brmDN gem)were co-expressed comparedwith thewild-type control (w1118). The levels of pMEK andMEK proteinwere reducedwhen both gem and brmDNwere co-
expressed (brmDN gem) relative to the wild-type control (w1118). (B) Quantiﬁcation of band intensities (see Materials and methods) In A +/– refers to ectopic expression of the protein..
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formation, the effects of Brm and Gem on the EGFR pathway are likely
to explain the observed defects in wing vein formation. However, wing
vein formation is also regulated by Notch and Dpp signaling (De Celis,
2003). We did not detect changes in Notch signaling in our
experiments; modulating Gem and Brm activity had no effect on the
expression of the Notch target, Cut, at the dorsal–ventral boundary of
the developing wing (Fig. 4). However, the importance of the
interaction of Gem and Brm in the modulation of the Dpp signaling
pathway in wing vein speciﬁcation remains to be determined. Since the
Brm complex has been shown to interact with Dpp signaling in wing
vein formation (Marenda et al., 2004), and Dpp signaling also affects
the expression of the EGFR signaling regulator, Rhomboid (Yu et al.,
1996), it is possible that Gem may also act to modulate Brm activity to
control Dpp signaling in wing vein speciﬁcation.
Possible role of Brm and Gem in EGFR–Ras–MAPK pathway regulation
during development and in tumorigenesis
In Drosophila, the EGFR–Ras–MAPK signaling pathway is important
for many aspects of differentiation during eye development (Baker and
Rubin, 1989; Baker and Rubin, 1992; Baker and Yu, 2001; Baonza et al.,
2001; Firth and Baker, 2005; Freeman, 1996; Zak and Shilo, 1992), and
promotes vein cell fate speciﬁcation in the developing wing (O'Keefe
et al., 2007a,b). By contrast, hyperactivation of Ras signaling using a
constitutively active allele (e.g. RasV12) leads to tissue overgrowth and
cooperates with tumor suppressor mutants to form invasive tumors
(Brumby and Richardson, 2005; Karim and Rubin, 1998). Therefore,
maintaining the appropriate balance in EGFR–Ras–MAPK signaling
activity in Drosophila is important for limiting cell proliferation and for
cell fate decisions during development. Our results presented here,
suggest that Gem and Brm may normally play a role in balancing
EGFR–Ras–MAPK signaling activity during development, thereby
affecting cell proliferation or differentiation.
In mammals, there is extensive evidence that the Ras–MAPK
pathway is activated in tumorigenesis, making this pathway an
important target for cancer therapy (Graham and Olson, 2007).
However, high levels of ﬂux through the Ras–MAPK signaling
pathway can lead to cellular senescence and additional mutations
are required to overcome this to allow tumor progression (Benanti
and Galloway, 2004; Coleman et al., 2004; Han and Sun, 2007;McCormick, 1998; Nakagawa and Opitz, 2007; Yaswen and Campisi,
2007). Indeed, in human tumor cell lines, lower levels of oncogenic K-
Ras expression appears to be favored (Konishi et al., 2007).
Consequently, the level of oncogenic Ras expression is critical for
whether it will play a role in cancer promotion or result in senescence.
In mammalian cells, the Brm and Brg1 complexes inhibit cell cycle
progression and are potential tumor suppressors (reviewed by
Muchardt and Yaniv, 2001; Reisman et al., 2009). Despite its role as
an inhibitor of DNA replication, Geminin is a candidate oncogene, as it
is frequently over-expressed in several types of human tumors and is
correlated with poor prognosis (reviewed by Montanari et al., 2006).
Our observation that Brm acts to promote EGFR–Ras–MAPK signaling
is seemingly at odds with Brm's role as a tumor suppressor. Likewise,
our observation that Gem acts to block EGFR–Ras–MAPK signaling is
opposite to its suspected oncogenic function. However, given the
ﬁndings that very high levels of Ras signaling may promote
senescence, the combined actions of decreased Brm function and
Gem over-expression, whichwould be expected to result in decreased
Ras signaling and prevent senescence, may indeed be tumor-
promoting. Our results showing that Brm and Gem act in an opposing
manner to regulate the EGFR–Ras–MAPK pathway, warrants further
investigation of the involvement of Brm and Gem with the Ras
signaling pathway during normal development and in tumorigenesis
in Drosophila, mammalian cells and in human cancer.
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